Gemtuzumab and pneumonia Patient Reports February 13, 2012

Gemtuzumab Side Effects Report #6119964-3
Gemtuzumab side effect was reported by a Physician from JAPAN on Mar 10, 2009. Male patient, 75 years of age, was diagnosed with myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: neutropenia, pneumonia , thrombocytopenia. Gemtuzumab dosage: 9 MG/M^2 ON DAY 1 AND 15. Patient died.

Gemtuzumab Side Effects Report #6119965-5
Gemtuzumab side effect was reported by a Physician from JAPAN on Mar 10, 2009. Female patient, 61 years of age, was diagnosed with myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: condition aggravated, neutropenia, pneumonia , thrombocytopenia. Gemtuzumab dosage: 9 MG/M^2 ON DAY 1 AND 15. Patient died.

Gemtuzumab Side Effects Report #5028040-2
Gemtuzumab side effect was reported by a Consumer or non-health professional from POLAND on May 30, 2006. Female patient, 23 years of age, was diagnosed with myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, hepatomegaly, hyperbilirubinaemia, pneumonia , prothrombin level increased, pseudomonal sepsis, white blood cell count decreased. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CANCIDAS, FENTANYL, AMIKIN. Patient recovered.

Gemtuzumab Side Effects Report #5035412-9
Gemtuzumab side effect was reported by a Consumer or non-health professional from POLAND on June 09, 2006. Female patient, 23 years of age, was diagnosed with myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: atelectasis, condition aggravated, fibrin d dimer increased, haemoglobin decreased, hepatomegaly, hyperbilirubinaemia, platelet count decreased, pneumonia , pseudomonal sepsis. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CANCIDAS, FENTANYL TRANSDERMAL SYSTEM, AMIKIN. Patient recovered.


Gemtuzumab Side Effects Report #4869653-8
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Dec 20, 2005. Male patient, 74 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: pneumonia . Gemtuzumab dosage: unknown. Patient died.

Gemtuzumab Side Effects Report #4875722-9
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Jan 02, 2006. Male patient, 74 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: pneumonia . Gemtuzumab dosage: unknown. Patient died.

Gemtuzumab Side Effects Report #6039174-8
Gemtuzumab side effect was reported by a Physician from BELGIUM on Jan 14, 2009. Female patient, 68 years of age, weighting 145.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: hepatitis , pneumonia , staphylococcal sepsis, stomatitis. Gemtuzumab dosage: unknown. During the same period patient was treated with ETOPOSIDE, IDARUBICIN. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4869659-9
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Dec 20, 2005. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: pneumonia . Gemtuzumab dosage: unknown. Patient died.

Gemtuzumab Side Effects Report #4875727-8
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Jan 02, 2006. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: pneumonia . Gemtuzumab dosage: unknown. Patient died.


Gemtuzumab Side Effects Report #4867042-3
Gemtuzumab side effect was reported by a Health Professional from NETHERLANDS on Mar 10, 2002. Male patient, 53 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: asthenia, blast cells present, blood lactate dehydrogenase increased, hypertension, hypotension, infection , pancytopenia, pneumonia , respiratory failure. Gemtuzumab dosage: CYCLE 1 (13-OCT-98) : CYCLE 2 CYCLE INTRAVENOUS; 2 (02-NOV-98) : 9 MG/M (2). During the same period patient was treated with CIPROXIN, DIFLUCAN, TAVEGIL. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #5297246-X
Gemtuzumab side effect was reported by a Physician from BELGIUM on Apr 10, 2007. Female patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: aspergillosis, neutropenia, pneumonia , sepsis , thrombocytopenia. Gemtuzumab dosage: DAILY DOSE 5 MG;CUMULATIVE DOSE 15 MG. Patient was hospitalized. Patient died on 11/08/2006.

Gemtuzumab Side Effects Report #5363276-2
Gemtuzumab side effect was reported by a Physician from ITALY on June 11, 2007. Male patient, weighting 136.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: colitis ischaemic, disease progression, intestinal haemorrhage, pneumonia . Gemtuzumab dosage: ACTUAL DOSE 5 MG; CUMMULATIVE DOSE 15 MG. During the same period patient was treated with MEROPENEM, LEVOFLOXACIN, VORICONAZOLE, GLAZIDIM, TRIDECANAMINE. Patient died on 12/05/2006.

Gemtuzumab Side Effects Report #5520558-9
Gemtuzumab side effect was reported by a Physician from BELGIUM on Nov 14, 2007. Female patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: aspergillosis, neutropenia, pneumonia , sepsis , thrombocytopenia. Gemtuzumab dosage: DAILY DOSE 5 MG;CUMULATIVE DOSE 15 MG. Patient was hospitalized. Patient died on 11/08/2006.

Gemtuzumab Side Effects Report #5520559-0
Gemtuzumab side effect was reported by a Physician from ITALY on Nov 14, 2007. Male patient, weighting 136.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: colitis ischaemic, disease progression, intestinal haemorrhage, pneumonia , respiratory distress. Gemtuzumab dosage: ACTUAL DOSE 5 MG; CUMMULATIVE DOSE 15 MG. During the same period patient was treated with MEROPENEM, LEVOFLOXACIN, VORICONAZOLE, GLAZIDIM, TRIDECANAMINE. Patient died on 12/05/2006.


Gemtuzumab Side Effects Report #5643261-3
Gemtuzumab side effect was reported by a Physician from GERMANY on Feb 25, 2008. Male patient was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: pneumonia , pulmonary haemorrhage, sepsis . Gemtuzumab dosage: 12 MG. During the same period patient was treated with DECORTIN. Patient died on 04/22/2007.

Gemtuzumab Side Effects Report #5660736-1
Gemtuzumab side effect was reported by a Physician from ITALY on Mar 06, 2008. Female patient was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: multi-organ failure, pneumonia . Gemtuzumab dosage: 6 MG/M2 (CUMULATIVE DOSE 10 MG). Patient died on 06/08/2007.

Gemtuzumab Side Effects Report #4786854-8
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 26, 2005. Male patient, 49 years of age, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: multi-organ failure, pneumonia , sepsis . Gemtuzumab dosage: unknown. During the same period patient was treated with DAUNORUBICIN, CYTARABINE, ETOPOSIDE. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #5623064-6
Gemtuzumab side effect was reported by a Physician from UNITED KINGDOM on Feb 08, 2008. Male patient was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: fungal infection , neutropenia, pneumonia . Gemtuzumab dosage: 3 MG/M^2 EVERY 1 TOT. During the same period patient was treated with DAUNORUBICIN. Patient was hospitalized. Patient died on 07/05/2007.

Gemtuzumab Side Effects Report #5625866-9
Gemtuzumab side effect was reported by a Physician from UNITED KINGDOM on Feb 08, 2008. Male patient was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: fungal infection , neutropenia, pneumonia . Gemtuzumab dosage: 3 MG/M^2 EVERY 1 TOT. During the same period patient was treated with DAUNORUBICIN. Patient was hospitalized. Patient died on 07/05/2007.


Gemtuzumab Side Effects Report #5643472-7
Gemtuzumab side effect was reported by a Physician from UNITED KINGDOM on Feb 25, 2008. Male patient was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: fungal infection , neutropenia, pneumonia . Gemtuzumab dosage: 3 MG/M^2 EVERY 1 TOT. During the same period patient was treated with DAUNORUBICIN. Patient was hospitalized. Patient died on 07/05/2007.